CTT Pharmaceutical Holdings, Inc.

CTTH · 8-K · Filed Oct 9 · 20:130001477932-26-006156Read the filing ›Open on SEC EDGAR

8-K

ctth_8k.htm

FORM 8-K

CURRENT REPORT

¶2

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 8, 2026 CTT PHARMACEUTICAL HOLDINGS, INC.

(Exact Name of Registrant as Specified in Its Charter)

Florida 333-292497 90-1253984 (State or Other Jurisdiction of Incorporation)

Name of Each Exchange on Which Registered Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

¶3

Item 4.01 Changes in Registrant’s Certifying Accountant.